Delcath Systems Inc.’s phase III FOCUS trial of its Hepzato Kit for metastatic hepatic dominant ocular melanoma (mOM) posted positive results for this challenging and aggressive cancer. Nearly a third of patients responded to the therapy – more than three times the rate seen in those receiving the best available choice – and just under 7% had a complete response. The treatment, known as Chemosat in Europe, isolates the liver for treatment then purifies the blood exiting the liver before it returns to circulation to reduce systemic effects. Read More
Medimaps Group SA has landed $20 million to expand its portfolio of bone health imaging software. The round was led by Swisscanto Invest, the asset management arm of the Zürcher Kantonalbank group, with participation from the Swiss Entrepreneurs Fund, Swisscom Ventures, and Verve Ventures. The company’s flagship product TBS (trabecular bone score) Insight is an artificial intelligence-powered medical software which provides information on bone quality from routine DXA and X-ray images. Read More
PERTH, Australia – Health care artificial intelligence (AI) company Harrison.ai has raised AU$129 million (US$97 million) in a series B round that will expand the company’s global footprint by commercializing its comprehensive clinical AI applications. Read More
LONDON – The latest epidemiological data from South Africa show it has entered a fourth wave of the COVID-19 pandemic, fueled by the Omicron variant of concern that was first detected in the country in late November. “We have moved from a total of 2,465 new cases last Thursday, when this variant was announced, to yesterday’s high of 11,535 [PCR confirmed infections],” said health minister Joseph Phaahla, in a briefing on Dec. 3. Read More
With large amounts of cash in hand from exponentially higher sales related to COVID-19, some Chinese med-tech companies are now implementing plans to continue growing in a post-pandemic world. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aurora Spine, Corza Medical, Depuy Synthes, Eurofins, Hillrom, Johnson & Johnson, Katena Products, Orthospin, Origimed, Pria Healthcare. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Caldera Medical. Read More
